Education
About Us
Working with TipRanks
Follow Us
NextCure Inc (NXTC)
NASDAQ:NXTC
Total Valuation
NextCure has a market cap or net worth of $44.11M. The enterprise value is $11.37M.
Market Cap$44.11M
Enterprise Value$11.37M
Share Statistics
NextCure has 3,560,410 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,560,410
Owned by Insiders―
Owned by Institutions45.47%
Financial Efficiency
NextCure’s return on equity (ROE) is -1.60 and return on invested capital (ROIC) is -145.43%.
Return on Equity (ROE)-1.60
Return on Assets (ROA)-1.11
Return on Invested Capital (ROIC)-145.43%
Return on Capital Employed (ROCE)-1.45
Revenue Per Employee0.00
Profits Per Employee-1.30M
Employee Count43
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of NextCure is ―. NextCure’s PEG ratio is 0.04.
PE Ratio―
PS Ratio0.00
PB Ratio1.15
Price to Fair Value1.15
Price to FCF-0.81
Price to Operating Cash Flow-0.88
PEG Ratio0.04
Income Statement
In the last 12 months, NextCure had revenue of 0.00 and earned -55.84M in profits. Earnings per share was -19.65.
Revenue0.00
Gross Profit-2.19M
Operating Income-57.62M
Pretax Income-55.84M
Net Income-55.84M
EBITDA-55.43M
Earnings Per Share (EPS)-19.65
Cash Flow
In the last 12 months, operating cash flow was -49.61M and capital expenditures 0.00, giving a free cash flow of -49.61M billion.
Operating Cash Flow-49.61M
Free Cash Flow-49.61M
Free Cash Flow per Share-13.93
Dividends & Yields
NextCure pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.31
52-Week Price Change40.48%
50-Day Moving Average12.65
200-Day Moving Average8.60
Relative Strength Index (RSI)47.98
Average Volume (3m)37.58K
Important Dates
NextCure upcoming earnings date is Apr 30, 2026, TBA (Confirmed).
Last Earnings DateMar 5, 2026
Next Earnings DateApr 30, 2026
Ex-Dividend Date―
Financial Position
NextCure as a current ratio of 4.14, with Debt / Equity ratio of 11.87%
Current Ratio4.14
Quick Ratio4.14
Debt to Market Cap0.10
Net Debt to EBITDA0.39
Interest Coverage Ratio0.00
Taxes
In the past 12 months, NextCure has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
NextCure EV to EBITDA ratio is -0.33, with an EV/FCF ratio of -0.37.
EV to Sales0.00
EV to EBITDA-0.33
EV to Free Cash Flow-0.37
EV to Operating Cash Flow-0.37
Balance Sheet
NextCure has $41.82M in cash and marketable securities with $4.15M in debt, giving a net cash position of $37.67M billion.
Cash & Marketable Securities$41.82M
Total Debt$4.15M
Net Cash$37.67M
Net Cash Per Share$10.58
Tangible Book Value Per Share$12.29
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for NextCure is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast3.78%